Andrew Jack
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
Papers in
- Epidemiology 11
- Hepatitis B Virus Studies 5
-
- Pharmaceutical Economics and Policy 7
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- Maimuna Mendy (3 shared papers)N. Maine (3 shared papers)H.C. Whittle (1 shared paper)A. Hall (1 shared paper)H Whittle (3 shared papers)A. J. Hall (3 shared papers)Simonetta Viviani (2 shared papers)R. Cartwright (3 shared papers)
- Journals
- BMJ (17 papers)The Lancet (5 papers)Water Science & Technology (2 papers)Annals of Oncology (2 papers)Haematologica (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Andrew Jack
54 papers receiving 976 citations
Peers
Comparison fields: 5 of 118
- Hepatology 229
- Epidemiology 450
- Pathology and Forensic Medicine 153
- Health 48
- Genetics 63
Countries citing papers authored by Andrew Jack
This map shows the geographic impact of Andrew Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Jack more than expected).
Fields of papers citing papers by Andrew Jack
This network shows the impact of papers produced by Andrew Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Jack. The network helps show where Andrew Jack may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew Jack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 273 | |
| 2 | 1999 | 143 | |
| 3 | 1999 | 120 | |
| 4 | 1993 | 79 | |
| 5 | 2001 | 63 | |
| 6 | 1997 | 40 | |
| 7 | 2008 | 26 | |
| 8 | 2007 | 21 | |
| 9 | Changing trends in the incidence of non-Hodgkin's lymphoma in Europe. Biomed Study Group. | 1997 | 20 |
| 10 | 2019 | 19 | |
| 11 | 2014 | 18 | |
| 12 | 2015 | 17 | |
| 13 | 2004 | 17 | |
| 14 | 2004 | 15 | |
| 15 | 2017 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2004 | 13 | |
| 18 | 2002 | 12 | |
| 19 | 2002 | 12 | |
| 20 | 2014 | 9 |
About Andrew Jack
Andrew Jack is a scholar working on Epidemiology, Economics and Econometrics, Pharmacology, General Health Professions and Pathology and Forensic Medicine, having authored 58 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmaceutical industry and healthcare (9 papers), Pharmaceutical Economics and Policy (7 papers), Health Services Management and Policy (5 papers), Hepatitis B Virus Studies (5 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Lymphoma Diagnosis and Treatment (5 papers), Vaccine Coverage and Hesitancy (3 papers) and Science, Research, and Medicine (3 papers). The work is most often cited by research in Hepatology (229 citations), Epidemiology (450 citations), Pathology and Forensic Medicine (153 citations), Health (48 citations) and Genetics (63 citations). Andrew Jack has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Maimuna Mendy, N. Maine, H.C. Whittle, A. Hall, H Whittle, A. J. Hall, Simonetta Viviani, R. Cartwright, H Brincker and Richard McNally. Their work appears in journals such as BMJ, The Lancet, Water Science & Technology, Annals of Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.